Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
VentX expression in tumor-associated macrophages promotes phagocytosis and immunity against pancreatic cancers
Yi Le, Hong Gao, William Richards, Lei Zhao, Ronald Bleday, Thomas Clancy, Zhenglun Zhu
Yi Le, Hong Gao, William Richards, Lei Zhao, Ronald Bleday, Thomas Clancy, Zhenglun Zhu
View: Text | PDF
Research Article Immunology

VentX expression in tumor-associated macrophages promotes phagocytosis and immunity against pancreatic cancers

  • Text
  • PDF
Abstract

Pancreatic ductal adenocarcinoma (PDA) is a lethal malignancy that has no effective treatment. The tumor microenvironment (TME) of PDA employs a multitude of immune derangement strategies to protect PDA from immune elimination. Tumor-associated macrophages (TAMs) have been implicated in the pathogenesis of immune suppression of the PDA TME; however, its underlying mechanisms remained largely unknown. Using primary patient samples, our studies showed that, in comparison with macrophages isolated from normal pancreatic tissues, the phagocytosis activity of the PDA TAMs was significantly reduced. We found that the expression of homeobox protein VentX, a master regulator of macrophage plasticity, was significantly decreased in the PDA TAMs. We demonstrated that VentX was required for phagocytosis and that restoration of VentX expression in PDA TAMs promoted phagocytosis through the regulation of the signaling cascades involved in the process. Using an ex vivo culture model of primary human PDA, we showed that VentX-modulated TAMs transformed the PDA TME from a protumor milieu to an antitumor microenvironment by rectifying differentiation, proliferation, and activation of PDA-infiltrating immune cells. Using NSG-PDX models of primary human PDAs, we showed that VentX-modulated TAMs exerted strong inhibition on PDA tumorigenesis in vivo. Taken together, our data revealed a central mechanism underlying immune evasion of PDA and a potential novel venue to improve PDA prognosis.

Authors

Yi Le, Hong Gao, William Richards, Lei Zhao, Ronald Bleday, Thomas Clancy, Zhenglun Zhu

×

Figure 2

Characterization of tumor-associated macrophages in pancreatic ductal adenocarcinoma.

Options: View larger image (or click on image) Download as PowerPoint
Characterization of tumor-associated macrophages in pancreatic ductal ad...
(A) The mRNA expression levels of indicated M1 and M2 cytokines in tumor-associated macrophages (TAMs) versus control macrophages, as determined by qRT-PCR. Results represent mean ± SD of 4 independent experiments. *P < 0.05, paired Student’s t test. (B) Cell surface expression of checkpoint inhibitor PD-L1 and Vista mRNA in TAMs and control macrophages isolated from adjacent normal pancreatic tissues. The expression level of PD-L1 was determined by flow cytometer analysis, and representative graphs are shown. n = 4. The mRNA expression levels of Vista were determined by qRT-PCR. Results represent mean ± SD of 8 independent experiments. P < 0.01, paired Student’s t test. (C) Paired comparison of qRT-PCR measurements of VentX mRNA expression in macrophages isolated from normal control tissues and TAMs of 17 patients. The relative VentX mRNA expression levels in normal macrophages were arbitrarily designated as 1. **P < 0.01, TAMs vs. adjacent normal macrophages, paired Student’s t test. n = 17. (D) Western blot analysis of endogenous VentX protein levels in macrophages isolated from normal control tissues and TAMs of 3 patients. The numbers indicate the relative fold difference of VentX proteins, as determined by ImageJ (NIH) software scanning. N, normal control tissue; Tu, tumor.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts